Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

New Dual-Target Vaccine Shows Promise Against Typhoid and Salmonella

The Phase 1 trial showed 100% of vaccine recipients developed strong immune responses with mild side effects, addressing 1.35 million US Salmonella infections annually.

Summary by News Medical
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.

4 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Wednesday, October 8, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal